Are the biggest Aim stocks also the best: Companies and Markets Show

This week, we return to our ultimate guide to Britain’s junior market, as we mark the release of Part Two of our Aim 100 Special Report.

We kick off with medical technology business Niox, which has just completed that relatively rare thing: a tender offer to shareholders. Julian Hofmann investigates whether the company is a safe haven in a volatile sector.

We then cast our ears to a stock that’s been an incredible rollercoaster ride in 2026: hydrogen electrolyser manufacturer ITM Power, whose shares soared and then came back down to earth again. Mike Fahy weighs up whether its commercial prospects square up with its still-lofty valuation.

Finally, Valeria Martinez considers data and information management business Restore. Valeria finds out if its turnaround plan is now bearing fruit.

Timestamps:
00:00 Intro
00:56 Niox
08:37 ITM Power
18:34 Restore

Listen to more podcasts from Investors’ Chronicle on Apple (podcasts.apple.com/gb/podcast/investors-chroni…), Spotify (open.spotify.com/show/0UXC2zQdVzl1n57gqO5oBp) and YouTube (youtube.com/user/InvestorsChronicle)

Investors' Chronicle (investorschronicle.co.uk/?utm_medium=referral&…) has supported private investors in the UK for over 160 years by highlighting rewarding investorschronicle.co.uk/investment-ideas/?utm… opportunities.

Investors' Chronicle is a service by the Financial Times (ft.com/?utm_medium=referral&utm_source=aca…).
Hosted on Acast. See acast.com/privacy for more information.